Soraya Allas

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 3

Top Topics

Postmenopausal Women

Top Venues

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Istvan Takacs, Emese Mezősi, Alfonso Soto, Peter Kamenickỷ, Marie-Lucile Figueres, Maria Angeles Galvez Moreno, Sandrine Lemoine, Françoise Borson-Chazot, Ismael Capel, Taha Ouldrouis, Nadège Lucas, Soraya Allas, Mark Sumeray, Michel Ovize, Michael Mannstadt
An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism. The Journal of clinical endocrinology and metabolism 109 (9) (2024)
Istvan Takacs, Emese Mezősi, Alfonso Soto, Peter Kamenickỷ, Marie-Lucile Figueres, Maria Angeles Galvez Moreno, Sandrine Lemoine, Françoise Borson-Chazot, Ismael Capel, Taha Ouldrouis, Nadège Lucas, Soraya Allas, Mark Sumeray, Michel Ovize, Michael Mannstadt
An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism. The Journal of clinical endocrinology and metabolism (2024)
Soraya Allas, Assumpta Caixàs, Christine Poitou, Muriel Coupaye, Denise Thuilleaux, Françoise Lorenzini, Gwenaëlle Diene, Antonino Crinò, Frédéric Illouz, Graziano Grugni, Diane Potvin, Sarah Bocchini, Thomas Delale, Thierry Abribat, Maithé Tauber
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial. PloS one 13 (1) (2018)